Latest Blogs

Jul 27, 2020
Ten years after losing my mom to breast cancer, I find myself reflecting on who I am today and what I have learned from the loss and grief that propelled me to relocate across the globe and dedicate my career to serving patients with cancer. 
Jul 23, 2020
Sometimes the best treatment isn't a medical intervention, but an emotional one, as Dr. Dawood Findakly discovered when a patient seemed to lose his will to live.
Jul 22, 2020
History has a long memory and the actions we take today will have ramifications far into the future, as three recent nonfiction books reminded me.
Jul 21, 2020
I counseled a patient whose cancer treatment had impacted her sex life that honesty is always the best policy, even if a secret is intended to spare someone's feelings.
Subscribe to this column

Edward Paul Balaban, DO, FACP, FASCO

Edward P. Balaban, DO, FACP, FASCO, is the Medical Director for the Cancer Care Partnership with Penn State University Cancer Institute and Professor of Medicine Penn State Hershey Cancer Institute. He currently serves as a Practice Guideline Implementation Network (PGIN) representative for Weight-Based Dosing Chemotherapy for Cancer Patients and Gastrointestinal Guideline Advisory Groups. Dr. Balaban is also Past President of the Pennsylvania Society of Oncology and Hematology and the delegate representing ASCO at the AMA-House of Delegates.

Jun 29, 2017
The most recent meeting of the AMA House of Delegates was a particularly important one for oncologists and cancer-related issues.
Nov 28, 2016
We (the ASCO delegation) have just returned from the interim American Medical Association (AMA) House of Delegates meeting in Orlando. ASCO proposed a resolution focused on the restrictive opioid policies being adopted by many states. Many of the state legislations include language restricting...
Jun 22, 2016
ASCO composed and successfully brought to the AMA-HOD several resolutions representing some of our most pressing concerns and/or initiatives, including regulations on handling hazardous materials, transparency on clinical pathways, reimbursement models, and Part B drug payments.
Jan 05, 2016
ASCO staff and  member representatives gathered in Atlanta for the AMA House of Delegates' recent meeting, and, as usual, listened, learned, and spoke on a number of topics.
Jun 18, 2015
The AMA House of Delegates (AMA-HOD) convened a few days after the ASCO Annual Meeting.  It was, in many ways, a continuation of many of the concerns reviewed at the annual ASCO gathering. The delegation representing ASCO is now composed of ASCO staff, along with Drs. Thomas Marsland, Ray Page,...
Jun 01, 2015
The annual ASCO gathering is now in its last 48 hours, and it has been interesting. I have heard discussions concerning payment reform, oncology medical homes, and value based care. The highlighted plenary presentations concerning what appears to be a major clinical advance in the treatment of...

Pages